Chernett Jorey 4

What Happened

• Jorey Chernett, a reported 10% beneficial owner of Oncology Institute, Inc. (TOI), acquired 30,000 shares in open-market/private purchases on May 19, 2026. The filing reports a weighted-average price of $4.09 per share, for a total reported cost of $122,700. This is a purchase (a bullish signal in the sense of insider buying), not a sale.

Key Details

• Transaction date: 2026-05-19; Form 4 filed: 2026-05-20 (timely).
• Shares purchased: 30,000; weighted-average price: $4.09; total reported value: $122,700.
• Price range: the filing says the shares were bought in multiple trades at prices from $4.04 to $4.14 (rounded); the $4.09 is a weighted average.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: Chernett offers to provide, on request, a breakdown of the number of shares bought at each separate price.
• No 10b5-1 plan, option exercise, gift, or tax-withholding noted in the disclosed transaction.

Context

• Insider purchases can be more informative than sales because they require personal cash outlay; as a 10% beneficial owner, Chernett is a significant shareholder rather than necessarily an executive. This filing shows additional stake was acquired via multiple open-market trades at modest prices around $4.10/share.